Prevalence and Factors Associated With Atrial Fibrillation in Patients With Type 2 Diabetes

NCT06174129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 427

Last updated 2023-12-18

No results posted yet for this study

Summary

This case-control study was conducted at Burapha University Hospital. The 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.

Conditions

Interventions

OTHER

Routine examinations

Electrocardiography and clinical parameters examinations, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications

Sponsors & Collaborators

  • Burapha University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-06-30
Completion
2023-07-31

Countries

  • Thailand

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06174129 on ClinicalTrials.gov